Vimarsana
Biggest News Aggregation in the World

Population Sciences Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Population Sciences Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Population Sciences Program Today - Breaking & Trending Today

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients - Vimarsana News

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.

Georgetown Lombardi Survivorship Research Initiative Seminar Series: "Oncology Primary Care Partnership to Improve Comprehensive Survivorship Care" - Vimarsana News

Georgetown Lombardi Survivorship Research Initiative Seminar Series: "Oncology Primary Care Partnership to Improve Comprehensive Survivorship Care"

The Georgetown Lombardi Survivorship Research Initiative works to optimize cancer survivorship across the lifespan and ensure equity for patients of every race, ethnicity, gender and socially determined status. This seminar series invites scientists from Georgetown and outside institutions to present their research. It also provides a forum in which individuals may present work in progress […]

Cedars-Sinai Launches Population Sciences Research Division - Los Angeles Business Journal - Vimarsana News

Cedars-Sinai Launches Population Sciences Research Division - Los Angeles Business Journal

Learn more about the new population science research division that Cedars-Sinai Health System is launching.

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors - Vimarsana News

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors

Researchers from City of Hope find only 30% of people with neuroendocrine tumors consider living longer to be their single top priority; 70% said addressing and overcoming pain, fatigue, or lack-of-function was more important than just prolonging life. JNCCN announces five new Associate Editors from Duke Cancer Institute, City of Hope, Mayo Clinic Cancer Center, University of Michigan...

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors - Vimarsana News

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors

/PRNewswire/ -- New research from cancer research and treatment organization City of Hope in the December 2022 issue of JNCCN—Journal of the National...